Mitiglinide

From Wikipedia, the free encyclopedia

Mitiglinide
Systematic (IUPAC) name
(-)-2(S)-Benzyl-4-(cis-perhydroisoindol-2-yl)butyric acid
Identifiers
CAS number 207844-01-7
ATC code A10BX
PubChem 121891
Chemical data
Formula C19H25NO3 
Mol. mass 315.41 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes oral

Mitiglinide (trade name Glufast) is a drug for the treatment of type 2 diabetes.

Mitiglinide belongs to the meglitinide class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda. The North America rights to mitiglinide are held by Elixir Pharmaceuticals. Mitiglinide has not yet gained FDA approval.

[edit] Pharmacology

Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) (K(ATP)) channels in pancreatic beta-cells

[edit] Dosage

Mitiglinide is delivered in tablet form.

[edit] External links